Shan, N. L., Gould, B., Wang, X., Bonora, G., Blenman, K., Foldi, J., . . . Pusztai, L. Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer. Elsevier.
Chicago Style (17th ed.) CitationShan, Naing Lin, et al. Circulating Tumor DNA Fraction Predicts Residual Cancer Burden Post-neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Elsevier.
MLA (9th ed.) CitationShan, Naing Lin, et al. Circulating Tumor DNA Fraction Predicts Residual Cancer Burden Post-neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Elsevier.
Warning: These citations may not always be 100% accurate.